BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26636646)

  • 1. Development of a ten-signature classifier using a support vector machine integrated approach to subdivide the M1 stage into M1a and M1b stages of nasopharyngeal carcinoma with synchronous metastases to better predict patients' survival.
    Jiang R; You R; Pei XQ; Zou X; Zhang MX; Wang TM; Sun R; Luo DH; Huang PY; Chen QY; Hua YJ; Tang LQ; Guo L; Mo HY; Qian CN; Mai HQ; Hong MH; Cai HM; Chen MY
    Oncotarget; 2016 Jan; 7(3):3645-57. PubMed ID: 26636646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision tree classification: A multicenter retrospective study.
    Liu Y; Zuo ZC; Zeng XY; Ma J; Ma CX; Chen RZ; Liang ZG; Chen KH; Li L; Qu S; Lu JY; Zhu XD
    Oral Oncol; 2024 Jun; 153():106834. PubMed ID: 38718458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.
    Lee SS; Kim SB; Park SI; Kim YH; Ryu JS; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
    Jpn J Clin Oncol; 2007 Nov; 37(11):829-35. PubMed ID: 17951334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment.
    Zou X; You R; Liu H; He YX; Xie GF; Xie ZH; Li JB; Jiang R; Liu LZ; Li L; Zhang MX; Liu YP; Hua YJ; Guo L; Qian CN; Mai HQ; Chen DP; Luo Y; Shen LF; Hong MH; Chen MY
    Eur J Cancer; 2017 May; 77():117-126. PubMed ID: 28391025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma.
    Shen L; Li W; Wang S; Xie G; Zeng Q; Chen C; Shi F; Zhang Y; Wu M; Shu W; Pan C; Xia Y; Wu P
    Radiology; 2016 Sep; 280(3):805-14. PubMed ID: 27023116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapy.
    Rusthoven CG; Lanning RM; Jones BL; Amini A; Koshy M; Sher DJ; Bowles DW; McDermott JD; Jimeno A; Karam SD
    Radiother Oncol; 2017 Jul; 124(1):139-146. PubMed ID: 28433411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.
    Tian YH; Zou WH; Xiao WW; Zeng L; Yuan X; Bai L; Lu T; Tian Y; Han F
    Head Neck; 2016 Aug; 38(8):1152-7. PubMed ID: 27220062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M1 stage subdivision and treatment outcome of patients with bone-only metastasis of nasopharyngeal carcinoma.
    Shen L; Dong J; Li S; Wang Y; Dong A; Shu W; Wu M; Pan C; Xia Y; Wu P
    Oncologist; 2015 Mar; 20(3):291-8. PubMed ID: 25660157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival.
    Wang HY; Sun BY; Zhu ZH; Chang ET; To KF; Hwang JS; Jiang H; Kam MK; Chen G; Cheah SL; Lee M; Liu ZW; Chen J; Zhang JX; Zhang HZ; He JH; Chen FL; Zhu XD; Huang MY; Liao DZ; Fu J; Shao Q; Cai MB; Du ZM; Yan LX; Hu CF; Ng HK; Wee JT; Qian CN; Liu Q; Ernberg I; Ye W; Adami HO; Chan AT; Zeng YX; Shao JY
    J Clin Oncol; 2011 Dec; 29(34):4516-25. PubMed ID: 22025164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit.
    Jiang Y; Xie J; Han Z; Liu W; Xi S; Huang L; Huang W; Lin T; Zhao L; Hu Y; Yu J; Zhang Q; Li T; Cai S; Li G
    Clin Cancer Res; 2018 Nov; 24(22):5574-5584. PubMed ID: 30042208
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis.
    Lin C; Lin S; Zhu L; Lin S; Pan J; Xu Y
    BMC Cancer; 2022 Jan; 22(1):35. PubMed ID: 34983459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomic prognostic factors and their potential roles in refining M1 classification for de novo metastatic nasopharyngeal carcinoma.
    Lu TZ; Zeng FJ; Hu YJ; Fang M; Zhong FY; Chen BJ; Zhang H; Guo QJ; Pan JJ; Gong XC; Huang SH; Liao ZH; Xia Y; Li JG
    Cancer Med; 2023 Dec; 12(24):22091-22102. PubMed ID: 38073447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined high-dose radiation therapy and systemic chemotherapy improves survival in patients with newly diagnosed metastatic nasopharyngeal cancer.
    Lin S; Tham IW; Pan J; Han L; Chen Q; Lu JJ
    Am J Clin Oncol; 2012 Oct; 35(5):474-9. PubMed ID: 21577086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal Carcinoma.
    Zheng SH; Liu SR; Wang HB; Wei YH; Li H; Wang GN; Huang ZL; Ding SR; Chen C; Tao YL; Li XH; Glorieux C; Huang P; Wu YF; Xia YF
    JAMA Netw Open; 2021 Dec; 4(12):e2138444. PubMed ID: 34902036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
    Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
    J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system.
    Shen LJ; Wang SY; Xie GF; Zeng Q; Chen C; Dong AN; Huang ZM; Pan CC; Xia YF; Wu PH
    Chin J Cancer; 2015 Aug; 34(10):450-8. PubMed ID: 26264052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of early radiological response to first-line platinum-containing chemotherapy in patients with metastatic nasopharyngeal carcinoma.
    Liu GY; Li WZ; Peng KQ; Lv X; Ke LR; Wu YS; Wang DL; Liang H; Liu KY; Lv SH; Guo X; Xiang YQ; Xia WX
    Cancer Med; 2020 Feb; 9(3):920-930. PubMed ID: 31834990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma].
    Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.